Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis

ClinicalTrials.gov ID: NCT02757352

Public ClinicalTrials.gov record NCT02757352. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 11:02 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 52-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD Naive Patients With Nonradiographic Axial Spondyloarthritis

Study identification

NCT ID
NCT02757352
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
303 participants

Conditions and interventions

Interventions

  • Ixekizumab Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 1, 2016
Primary completion
Feb 28, 2019
Completion
May 6, 2019
Last update posted
Mar 12, 2020

2016 – 2019

United States locations

U.S. sites
25
U.S. states
17
U.S. cities
25
Facility City State ZIP Site status
Arizona Arthritis Research, PLC Phoenix Arizona 85032
TriWest Research Assocaites El Cajon California 92020
Rheumatology Center of San Diego Escondido California 92025
Care Access Research - Huntington Beach Huntington Beach California 92648
Desert Medical Advances Palm Desert California 92260
Inlande Rheumatology Clinical Trials Upland California 91786
Arthritis Assoc. & Osteoporosis Ctr of Colorado Springs, LLC Colorado Springs Colorado 80920
Clinical Research Center of CT/NY Danbury Connecticut 06810
Sarasota Arthritis Center Sarasota Florida 34239
West Broward Rheumatology Associates, Inc Tamarac Florida 33321
Marietta Rheumatology Marietta Georgia 30060
Institute of Arthritis Research Idaho Falls Idaho 83404
The Arthritis & Diabetes Clinic Inc. Monroe Louisiana 71203
Osteoporosis And Clinical Trial Center Cumberland Maryland 21502
Osteoporosis And Clinical Trial Center Hagerstown Maryland 21740
Glacier View Research Institute Kalispell Montana 59901
Physician Research Collaboration, LLC Lincoln Nebraska 68516
Weill Cornell Physicians at Brooklyn Heights Brooklyn New York 11201
Shanahan Rheumatology & Immunotherapy Raleigh North Carolina 27617
Carolina Arthritis Associates Wilmington North Carolina 28401
Oregon Health and Science University Portland Oregon 97239
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
Articularis Healthcare Group, INC dba Columbia Arthritis Ctr Columbia South Carolina 29204
Seattle Rheumatology Associates, P.L.L.C. Seattle Washington 98122
Arthritis Northwest Rheumatology Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 84 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02757352, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 12, 2020 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02757352 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →